{"id":"https://openalex.org/W4284706566","doi":"https://doi.org/10.3390/ph15070839","title":"New Therapeutic Approaches in Treatment of Dyslipidaemia\u2014A Narrative Review","display_name":"New Therapeutic Approaches in Treatment of Dyslipidaemia\u2014A Narrative Review","alternate_titles":[],"publication_year":2022,"publication_date":"2022-07-07","ids":{"openalex":"https://openalex.org/W4284706566","doi":"https://doi.org/10.3390/ph15070839","pmid":"https://pubmed.ncbi.nlm.nih.gov/35890138","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9324773"},"language":"en","primary_location":{"id":"doi:10.3390/ph15070839","doi":"https://doi.org/10.3390/ph15070839","is_oa":true,"landing_page_url":"https://doi.org/10.3390/ph15070839","pdf_url":"https://www.mdpi.com/1424-8247/15/7/839/pdf?version=1657189502","source":{"id":"https://openalex.org/S16322639","display_name":"Pharmaceuticals","issn_l":"1424-8247","issn":["1424-8247"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceuticals","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4284706566"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.mdpi.com/1424-8247/15/7/839/pdf?version=1657189502","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010494909","display_name":"Iveta Mer\u0107ep","orcid":"https://orcid.org/0000-0003-2824-9222","observed_orcids":["https://orcid.org/0000-0003-2824-9222"]},"institutions":[{"id":"https://openalex.org/I138937732","display_name":"University Hospital Centre Zagreb","ror":"https://ror.org/00r9vb833","country_code":"HR","type":"healthcare","lineage":["https://openalex.org/I138937732"]},{"id":"https://openalex.org/I181343428","display_name":"University of Zagreb","ror":"https://ror.org/00mv6sv71","country_code":"HR","type":"education","lineage":["https://openalex.org/I181343428"]}],"countries":["HR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Iveta Mer\u0107ep","raw_affiliation_strings":["Division of Clinical Pharmacology, Department of Internal Medicine, University Hospital Centre Zagreb, 10000 Zagreb, Croatia","Division of Clinical Pharmacology, Department of Internal Medicine, University of Zagreb School of Medicine, 10000 Zagreb, Croatia"],"raw_orcid":"https://orcid.org/0000-0003-2824-9222","affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology, Department of Internal Medicine, University Hospital Centre Zagreb, 10000 Zagreb, Croatia","institution_ids":["https://openalex.org/I138937732"]},{"raw_affiliation_string":"Division of Clinical Pharmacology, Department of Internal Medicine, University of Zagreb School of Medicine, 10000 Zagreb, Croatia","institution_ids":["https://openalex.org/I181343428"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018038658","display_name":"Dominik Striki\u0107","orcid":"https://orcid.org/0000-0003-3977-9712","observed_orcids":["https://orcid.org/0000-0003-3977-9712"]},"institutions":[{"id":"https://openalex.org/I138937732","display_name":"University Hospital Centre Zagreb","ror":"https://ror.org/00r9vb833","country_code":"HR","type":"healthcare","lineage":["https://openalex.org/I138937732"]}],"countries":["HR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dominik Striki\u0107","raw_affiliation_strings":["Division of Clinical Pharmacology, Department of Internal Medicine, University Hospital Centre Zagreb, 10000 Zagreb, Croatia"],"raw_orcid":"https://orcid.org/0000-0003-3977-9712","affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology, Department of Internal Medicine, University Hospital Centre Zagreb, 10000 Zagreb, Croatia","institution_ids":["https://openalex.org/I138937732"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046833003","display_name":"Ana Marija Sli\u0161kovi\u0107","orcid":"https://orcid.org/0000-0001-6622-7572","observed_orcids":["https://orcid.org/0000-0001-6622-7572"]},"institutions":[{"id":"https://openalex.org/I138937732","display_name":"University Hospital Centre Zagreb","ror":"https://ror.org/00r9vb833","country_code":"HR","type":"healthcare","lineage":["https://openalex.org/I138937732"]}],"countries":["HR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ana Marija Sli\u0161kovi\u0107","raw_affiliation_strings":["Department of Cardiovascular Diseases, University Hospital Centre Zagreb, 10000 Zagreb, Croatia"],"raw_orcid":"https://orcid.org/0000-0001-6622-7572","affiliations":[{"raw_affiliation_string":"Department of Cardiovascular Diseases, University Hospital Centre Zagreb, 10000 Zagreb, Croatia","institution_ids":["https://openalex.org/I138937732"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045816461","display_name":"\u017deljko Reiner","orcid":"https://orcid.org/0000-0002-4932-4212","observed_orcids":["https://orcid.org/0000-0002-4932-4212"]},"institutions":[{"id":"https://openalex.org/I138937732","display_name":"University Hospital Centre Zagreb","ror":"https://ror.org/00r9vb833","country_code":"HR","type":"healthcare","lineage":["https://openalex.org/I138937732"]}],"countries":["HR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"\u017deljko Reiner","raw_affiliation_strings":["Division of Metabolic Diseases, Department of Internal Medicine, University Hospital Centre Zagreb, 10000 Zagreb, Croatia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Metabolic Diseases, Department of Internal Medicine, University Hospital Centre Zagreb, 10000 Zagreb, Croatia","institution_ids":["https://openalex.org/I138937732"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5010494909"],"corresponding_institution_ids":["https://openalex.org/I138937732","https://openalex.org/I181343428"],"apc_list":{"value":2000,"currency":"CHF","value_usd":2094},"apc_paid":{"value":2000,"currency":"CHF","value_usd":2094},"fwci":1.5201,"has_fulltext":true,"cited_by_count":39,"citation_normalized_percentile":{"value":0.84197377,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"15","issue":"7","first_page":"839","last_page":"839"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.9909999966621399},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.9169999957084656},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.8600000143051147},{"id":"https://openalex.org/keywords/ezetimibe","display_name":"ezetimibe","score":0.9990000128746033},{"id":"https://openalex.org/keywords/bempedoic-acid","display_name":"bempedoic acid","score":0.9929999709129333},{"id":"https://openalex.org/keywords/pcsk9-inhibitors","display_name":"PCSK9 inhibitors","score":0.9980000257492065},{"id":"https://openalex.org/keywords/inclisiran","display_name":"inclisiran","score":0.9909999966621399},{"id":"https://openalex.org/keywords/sirna","display_name":"siRNA","score":0.7509999871253967},{"id":"https://openalex.org/keywords/pelacarsen","display_name":"pelacarsen","score":0.8790000081062317},{"id":"https://openalex.org/keywords/antisense-oligonucleotides","display_name":"antisense oligonucleotides","score":0.8759999871253967},{"id":"https://openalex.org/keywords/lipoprotein-a","display_name":"lipoprotein(a)","score":0.8939999938011169},{"id":"https://openalex.org/keywords/volanesorsen","display_name":"volanesorsen","score":0.9959999918937683},{"id":"https://openalex.org/keywords/olezarsen","display_name":"olezarsen","score":0.9449999928474426},{"id":"https://openalex.org/keywords/angptl3-inhibitors","display_name":"ANGPTL3 inhibitors","score":0.9620000123977661},{"id":"https://openalex.org/keywords/evinacumab","display_name":"evinacumab","score":0.9929999709129333},{"id":"https://openalex.org/keywords/familial-hypercholesterolemia","display_name":"familial hypercholesterolemia","score":0.9819999933242798},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.5590000152587891}],"concepts":[{"id":"https://openalex.org/C2778657065","wikidata":"https://www.wikidata.org/wiki/Q417997","display_name":"Ezetimibe","level":3,"score":0.9499841928482056},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7944684028625488},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.6583250761032104},{"id":"https://openalex.org/C11772777","wikidata":"https://www.wikidata.org/wiki/Q423126","display_name":"Chylomicron","level":5,"score":0.6202735304832458},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4704258441925049},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.45651718974113464},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4250723719596863},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.40825533866882324},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.38032349944114685},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3557124137878418},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.3367347717285156},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.2615472674369812},{"id":"https://openalex.org/C8243546","wikidata":"https://www.wikidata.org/wiki/Q419074","display_name":"Very low-density lipoprotein","level":4,"score":0.0878954529762268}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3390/ph15070839","doi":"https://doi.org/10.3390/ph15070839","is_oa":true,"landing_page_url":"https://doi.org/10.3390/ph15070839","pdf_url":"https://www.mdpi.com/1424-8247/15/7/839/pdf?version=1657189502","source":{"id":"https://openalex.org/S16322639","display_name":"Pharmaceuticals","issn_l":"1424-8247","issn":["1424-8247"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceuticals","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9324773","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9324773/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceuticals (Basel)","raw_type":"Text"},{"id":"pmid:35890138","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35890138","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceuticals (Basel, Switzerland)","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:cd9d63e1d97449f6b495b31c5c333294","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/cd9d63e1d97449f6b495b31c5c333294","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmaceuticals, Vol 15, Iss 7, p 839 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3390/ph15070839","doi":"https://doi.org/10.3390/ph15070839","is_oa":true,"landing_page_url":"https://doi.org/10.3390/ph15070839","pdf_url":"https://www.mdpi.com/1424-8247/15/7/839/pdf?version=1657189502","source":{"id":"https://openalex.org/S16322639","display_name":"Pharmaceuticals","issn_l":"1424-8247","issn":["1424-8247"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceuticals","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4284706566.pdf","grobid_xml":"https://content.openalex.org/works/W4284706566.grobid-xml"},"referenced_works_count":67,"referenced_works":["https://openalex.org/W1520609538","https://openalex.org/W1958022600","https://openalex.org/W1980114153","https://openalex.org/W1992084132","https://openalex.org/W2039944972","https://openalex.org/W2046959088","https://openalex.org/W2058745674","https://openalex.org/W2088469693","https://openalex.org/W2093260782","https://openalex.org/W2098890974","https://openalex.org/W2125963456","https://openalex.org/W2134120087","https://openalex.org/W2142526970","https://openalex.org/W2143741651","https://openalex.org/W2151714890","https://openalex.org/W2167045683","https://openalex.org/W2234444148","https://openalex.org/W2266139607","https://openalex.org/W2291773302","https://openalex.org/W2411942702","https://openalex.org/W2475261460","https://openalex.org/W2559896499","https://openalex.org/W2577732862","https://openalex.org/W2593823350","https://openalex.org/W2595721094","https://openalex.org/W2596179513","https://openalex.org/W2617605538","https://openalex.org/W2708266792","https://openalex.org/W2738949577","https://openalex.org/W2785715927","https://openalex.org/W2808641584","https://openalex.org/W2899997727","https://openalex.org/W2900034165","https://openalex.org/W2909249787","https://openalex.org/W2914063169","https://openalex.org/W2914692842","https://openalex.org/W2922038538","https://openalex.org/W2928534885","https://openalex.org/W2936801925","https://openalex.org/W2937688839","https://openalex.org/W2941139188","https://openalex.org/W2953804067","https://openalex.org/W2966503756","https://openalex.org/W2987850771","https://openalex.org/W2997944188","https://openalex.org/W3006057482","https://openalex.org/W3021936342","https://openalex.org/W3035937686","https://openalex.org/W3048383431","https://openalex.org/W3061843793","https://openalex.org/W3081748070","https://openalex.org/W3091533352","https://openalex.org/W3101723617","https://openalex.org/W3142840603","https://openalex.org/W3146122039","https://openalex.org/W3163698300","https://openalex.org/W3181528249","https://openalex.org/W3183857127","https://openalex.org/W3192118072","https://openalex.org/W3213036992","https://openalex.org/W4205868548","https://openalex.org/W4206543011","https://openalex.org/W4211127626","https://openalex.org/W4220815749","https://openalex.org/W4223944605","https://openalex.org/W6714820245","https://openalex.org/W6782078855"],"related_works":["https://openalex.org/W2755718870","https://openalex.org/W4382934914","https://openalex.org/W3010695220","https://openalex.org/W4362720976","https://openalex.org/W4288060117","https://openalex.org/W3104177744","https://openalex.org/W2788081240","https://openalex.org/W2794961123","https://openalex.org/W3129180352","https://openalex.org/W2976066646"],"abstract_inverted_index":{"Dyslipidaemia":[0],"is":[1,139,156,178],"a":[2,12,23,53,88,211],"well-known":[3],"risk":[4],"factor":[5],"for":[6,34,52,101,114,185,202,222],"the":[7,25,41,58,102,157,172,186,198,203],"development":[8],"of":[9,15,60,104,188,205,214],"cardiovascular":[10],"disease,":[11],"leading":[13],"cause":[14],"morbidity":[16],"and":[17,36,143,151,166,170,200],"mortality":[18],"in":[19,57,73,83,90],"developed":[20,221],"countries.":[21],"As":[22],"consequence,":[24],"medical":[26],"community":[27],"has":[28,79],"been":[29,80],"dealing":[30],"with":[31,75,87,116,193],"this":[32],"problem":[33],"decades,":[35],"traditional":[37],"statin":[38,121,123],"therapy":[39],"remains":[40],"cornerstone":[42],"therapeutic":[43],"approach.":[44],"However,":[45],"clinical":[46,85],"trials":[47],"have":[48],"observed":[49],"remarkable":[50],"results":[51,70],"few":[54],"agents":[55,216],"effective":[56],"treatment":[59,103,113,187,204],"elevated":[61],"serum":[62],"lipid":[63,118,223],"levels.":[64,154],"Ezetimibe":[65],"showed":[66],"good":[67],"but":[68],"limited":[69],"when":[71],"used":[72,110,218],"combination":[74,124],"statins.":[76],"Bempedoic":[77],"acid":[78],"thoroughly":[81],"studied":[82],"multiple":[84],"trials,":[86],"reduction":[89],"LDL":[91],"cholesterol":[92],"by":[93,197],"approximately":[94],"15%.":[95],"The":[96,182],"first":[97,158],"approved":[98,196],"monoclonal":[99],"antibodies":[100],"dyslipidaemia,":[105],"PCSK9":[106],"inhibitors,":[107],"are":[108,190],"currently":[109,179,217],"as":[111,137],"second-line":[112],"patients":[115],"unregulated":[117],"levels":[119],"on":[120],"or":[122,219],"therapy.":[125],"A":[126],"new":[127,215],"siRNA":[128],"molecule,":[129],"inclisiran,":[130],"demonstrates":[131],"great":[132],"potential,":[133],"particularly":[134],"concerning":[135],"compliance,":[136],"it":[138],"administered":[140],"twice":[141],"yearly":[142],"pelacarsen,":[144],"an":[145],"antisense":[146],"oligonucleotide":[147],"that":[148,160],"targets":[149],"lipoprotein(a)":[150],"lowers":[152],"its":[153],"Volanesorsen":[155],"drug":[159],"was":[161],"designed":[162],"to":[163],"target":[164],"chylomicrons":[165],"lower":[167],"triglyceride":[168],"levels,":[169],"olezarsen,":[171],"next":[173],"in-line":[174],"chylomicron":[175],"lowering":[176,224],"agent,":[177],"being":[180,220],"researched.":[181],"newest":[183],"possibilities":[184],"dyslipidaemia":[189],"ANGPTL3":[191],"inhibitors":[192],"evinacumab,":[194],"already":[195],"FDA,":[199],"EMA":[201],"familial":[206],"hypercholesterolemia.":[207],"This":[208],"article":[209],"provides":[210],"short":[212],"summary":[213],"treatment.":[225]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4284706566","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":13},{"year":2022,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2022-07-08T00:00:00"}
